Proposed Information Collection Activity; Comment Request, 59155-59156 [2015-24863]
Download as PDF
59155
Federal Register / Vol. 80, No. 190 / Thursday, October 1, 2015 / Notices
physicians perform chest x-rays and
laboratory tests that aid in the
identification of tuberculosis infection
(Class B1 applicants) and diagnosis of
active tuberculosis disease (Class A,
inadmissible applicants). CDC uses
these classifications to report new
immigrant and refugee arrivals with a
higher risk of developing TB disease to
U.S. state and local health departments
for further follow-up. Some information
that panel physicians collect as part of
requesting this data to be sent by panel
physicians once per year. The
consequences of reducing this frequency
would be the loss of monitoring
program impact and TB burdens in
mobile populations and immigrants and
refugees coming to the United States on
an annual basis. The total hours
requested is 2,648. There is no cost to
the respondents other than their time.
the medical exam is not reported on the
standard Department of State forms (DSforms), thereby preventing CDC from
evaluating TB trends in globally mobile
populations and monitoring program
effectiveness.
CDC currently collects this data based
on past understanding of panel
physicians as instrumentalities of the
federal government. CDC requests OMB
approval now to comply with PRA
requirements for data collection. CDC is
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Form name
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
International Panel Physicians (All sites) .......
TB Indicators Excel Spreadsheet ..................
353
1
7.5
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2015–24946 Filed 9–30–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Comment Request
Proposed Projects
Title: Child Support Document
Exchange System (CSDES).
OMB No.: 0970–0435.
Description: The federal Office of
Child Support Enforcement offers the
Child Support Document Exchange
System (CSDES) application within the
OCSE Child Support Portal. The CSDES
provides state agencies with a
centralized, secure system for
authorized users in state child support
agencies to electronically exchange
child support and spousal support case
information with other state child
support agencies. Using the CSDES
benefits state child support agencies by
reducing delays, costs, and barriers
associated with interstate case
processing, increasing state collections,
improving document security,
standardizing data sharing, increasing
state participation, and improving case
processing and overall child and
spousal support outcomes.
The activities associated with the
CSDES are authorized by (1) 42 U.S.C.
652(a)(7), which requires OCSE to
provide technical assistance to the states
to help them establish effective systems
for collecting child support and spousal
support, thereby helping state child
support agencies fulfill the federal
requirement to transmit requests for
child support case information and
provide requested information
electronically to the greatest extent
possible as required by 45 CFR
303.7(a)(5); and (2) 42 U.S.C. 666(c)(1),
which requires state child support
agencies to have expedited procedures
to obtain and promptly share
information with other state child
support agencies.
Respondents: State Child Support
Agencies.
ANNUAL BURDEN ESTIMATES
Number of
respondents
Number of
responses per
respondent
Average
burden hours
per response
Total burden
hours
On-line Data Entry Screens .............................................................................
mstockstill on DSK4VPTVN1PROD with NOTICES6
Instrument
52
4,272
.0166667
(60 seconds)
3,702.41
In compliance with the requirements
of Section 506(c)(2)(A) of the Paperwork
Reduction Act of 1995, the
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
information can be obtained and
comments may be forwarded by writing
to the Administration for Children and
Families, Office of Planning, Research
and Evaluation, 370 L’Enfant
Promenade SW., Washington, DC 20447,
VerDate Sep<11>2014
21:04 Sep 30, 2015
Jkt 238001
Attn: ACF Reports Clearance Officer.
Email address: infocollection@
acf.hhs.gov. All requests should be
identified by the title of the information
collection.
The Department specifically requests
comments on: (a) Whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
the quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Consideration will be given to
E:\FR\FM\01OCN1.SGM
01OCN1
59156
Federal Register / Vol. 80, No. 190 / Thursday, October 1, 2015 / Notices
comments and suggestions submitted
within 60 days of this publication.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2015–24863 Filed 9–30–15; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2015–N–0001]
Joint Meeting of the Antimicrobial
Drugs Advisory Committee (Formerly
Known as the Anti-Infective Drugs
Advisory Committee) and the Drug
Safety and Risk Management Advisory
Committee; Notice of Meeting
AGENCY:
Food and Drug Administration,
HHS.
mstockstill on DSK4VPTVN1PROD with NOTICES6
ACTION:
Notice.
This notice announces a forthcoming
meeting of a public advisory committee
of the Food and Drug Administration
(FDA). The meeting will be open to the
public.
Name of Committees: Antimicrobial
Drugs Advisory Committee (formerly
known as the Anti-Infective Drugs
Advisory Committee) and the Drug
Safety and Risk Management Advisory
Committee.
General Function of the Committees:
To provide advice and
recommendations to the Agency on
FDA’s regulatory issues.
Date and Time: The meeting will be
held on November 5, 2015, from 8 a.m.
to 6 p.m.
Location: FDA White Oak Campus,
10903 New Hampshire Ave., Bldg. 31
Conference Center, the Great Room (Rm.
1503), Silver Spring, MD 20993–0002.
Answers to commonly asked questions
including information regarding special
accommodations due to a disability,
visitor parking, and transportation may
be accessed at: https://www.fda.gov/
AdvisoryCommittees/AboutAdvisory
Committees/ucm408555.htm.
Contact Person: Jennifer Shepherd,
Center for Drug Evaluation and
Research, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 31, Rm. 2417, Silver Spring,
MD 20993–0002, 301–796–9001, FAX:
301–847–8533, email: AMDAC@
fda.hhs.gov, or FDA Advisory
Committee Information Line, 1–800–
741–8138 (301–443–0572 in the
Washington, DC area). A notice in the
Federal Register about last minute
modifications that impact a previously
announced advisory committee meeting
VerDate Sep<11>2014
21:04 Sep 30, 2015
Jkt 238001
cannot always be published quickly
enough to provide timely notice.
Therefore, you should always check the
Agency’s Web site at https://www.fda.
gov/AdvisoryCommittees/default.htm
and scroll down to the appropriate
advisory committee meeting link, or call
the advisory committee information line
to learn about possible modifications
before coming to the meeting.
Agenda: The committees will discuss
the risks and benefits of the systemic
fluoroquinolone antibacterial drugs for
the treatment of acute bacterial sinusitis,
acute bacterial exacerbation of chronic
bronchitis in patients who have chronic
obstructive pulmonary disease, and
uncomplicated urinary tract infections
in the context of available safety
information and the treatment effect of
antibacterial drugs in these clinical
conditions.
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its Web site prior to the
meeting, the background material will
be made publicly available at the
location of the advisory committee
meeting, and the background material
will be posted on FDA’s Web site after
the meeting. Background material is
available at https://www.fda.gov/
AdvisoryCommittees/Calendar/
default.htm. Scroll down to the
appropriate advisory committee meeting
link.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committees. Written
submissions may be made to the contact
person on or before October 22, 2015.
Oral presentations from the public will
be scheduled between approximately 1
p.m. and 2:30 p.m. Those individuals
interested in making formal oral
presentations should notify the contact
person and submit a brief statement of
the general nature of the evidence or
arguments they wish to present, the
names and addresses of proposed
participants, and an indication of the
approximate time requested to make
their presentation on or before October
14, 2015. Time allotted for each
presentation may be limited. If the
number of registrants requesting to
speak is greater than can be reasonably
accommodated during the scheduled
open public hearing session, FDA may
conduct a lottery to determine the
speakers for the scheduled open public
hearing session. The contact person will
notify interested persons regarding their
request to speak by October 15, 2015.
Persons attending FDA’s advisory
committee meetings are advised that the
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
Agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with disabilities.
If you require accommodations due to a
disability, please contact Jennifer
Shepherd at least 7 days in advance of
the meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/Advisory
Committees/AboutAdvisoryCommittees/
ucm111462.htm for procedures on
public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: September 25, 2015.
Jill Hartzler Warner,
Associate Commissioner for Special Medical
Programs.
[FR Doc. 2015–24836 Filed 9–30–15; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Docket No. FDA–2015–N–0001]
Request for Nominations for
Individuals and Consumer
Organizations for Advisory
Committees
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is requesting that
any consumer organizations interested
in participating in the selection of
voting and/or nonvoting consumer
representatives to serve on its advisory
committees or panels notify FDA in
writing. FDA is also requesting
nominations for voting and/or
nonvoting consumer representatives to
serve on advisory committees and/or
panels for which vacancies currently
exist or are expected to occur in the near
future. Nominees recommended to serve
as a voting or nonvoting consumer
representative may be self-nominated or
may be nominated by a consumer
organization. Nominations will be
accepted for current vacancies and for
those that will or may occur through
December 31, 2015.
DATES: Any consumer organization
interested in participating in the
selection of an appropriate voting or
nonvoting member to represent
consumer interests on an FDA advisory
SUMMARY:
E:\FR\FM\01OCN1.SGM
01OCN1
Agencies
[Federal Register Volume 80, Number 190 (Thursday, October 1, 2015)]
[Notices]
[Pages 59155-59156]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-24863]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Proposed Information Collection Activity; Comment Request
Proposed Projects
Title: Child Support Document Exchange System (CSDES).
OMB No.: 0970-0435.
Description: The federal Office of Child Support Enforcement offers
the Child Support Document Exchange System (CSDES) application within
the OCSE Child Support Portal. The CSDES provides state agencies with a
centralized, secure system for authorized users in state child support
agencies to electronically exchange child support and spousal support
case information with other state child support agencies. Using the
CSDES benefits state child support agencies by reducing delays, costs,
and barriers associated with interstate case processing, increasing
state collections, improving document security, standardizing data
sharing, increasing state participation, and improving case processing
and overall child and spousal support outcomes.
The activities associated with the CSDES are authorized by (1) 42
U.S.C. 652(a)(7), which requires OCSE to provide technical assistance
to the states to help them establish effective systems for collecting
child support and spousal support, thereby helping state child support
agencies fulfill the federal requirement to transmit requests for child
support case information and provide requested information
electronically to the greatest extent possible as required by 45 CFR
303.7(a)(5); and (2) 42 U.S.C. 666(c)(1), which requires state child
support agencies to have expedited procedures to obtain and promptly
share information with other state child support agencies.
Respondents: State Child Support Agencies.
Annual Burden Estimates
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Instrument Number of responses per hours per Total burden
respondents respondent response hours
----------------------------------------------------------------------------------------------------------------
On-line Data Entry Screens.................. 52 4,272 .0166667 3,702.41
(60 seconds)
----------------------------------------------------------------------------------------------------------------
In compliance with the requirements of Section 506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the Administration for Children and
Families is soliciting public comment on the specific aspects of the
information collection described above. Copies of the proposed
collection of information can be obtained and comments may be forwarded
by writing to the Administration for Children and Families, Office of
Planning, Research and Evaluation, 370 L'Enfant Promenade SW.,
Washington, DC 20447, Attn: ACF Reports Clearance Officer. Email
address: infocollection@acf.hhs.gov. All requests should be identified
by the title of the information collection.
The Department specifically requests comments on: (a) Whether the
proposed collection of information is necessary for the proper
performance of the functions of the agency, including whether the
information shall have practical utility; (b) the accuracy of the
agency's estimate of the burden of the proposed collection of
information; (c) the quality, utility, and clarity of the information
to be collected; and (d) ways to minimize the burden of the collection
of information on respondents, including through the use of automated
collection techniques or other forms of information technology.
Consideration will be given to
[[Page 59156]]
comments and suggestions submitted within 60 days of this publication.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2015-24863 Filed 9-30-15; 8:45 am]
BILLING CODE 4184-01-P